| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Rosetta Genomics Ltd
Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
Other Non-Cash Items
Rosetta Genomics Ltd
Other Non-Cash Items Peer Comparison
CLGN
KMDA
URGN
ENTX
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Other Non-Cash Items
$1.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Other Non-Cash Items
$2.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Other Non-Cash Items
$2.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
67%
|
CAGR 10-Years
-8%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Other Non-Cash Items
$20.7m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Other Non-Cash Items
$1.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Other Non-Cash Items
₪700k
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-3%
|
See Also
What is Rosetta Genomics Ltd's Other Non-Cash Items?
Other Non-Cash Items
1.4m
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Other Non-Cash Items amounts to 1.4m USD.
What is Rosetta Genomics Ltd's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
25%
Over the last year, the Other Non-Cash Items growth was -43%. The average annual Other Non-Cash Items growth rates for Rosetta Genomics Ltd have been 6% over the past three years , 25% over the past five years .
You don't have any saved screeners yet
